Our findings similarly indicate that elevated levels of CD8+CD28− T-cell expression are associated with a poor OS in all patients, although are not predictive of tumor response or PFS, neither did they have an effective prognostic value in the PD-1 inhibitor treatment subgroup. This evidence concerns the gene CD8A and neoplasm.